Citation: K. Duncan et al., IMPROVED FLUOROMETRIC AND CHROMATOGRAPHIC METHODS FOR THE QUANTIFICATION OF FUMONISINS B-1, B-2 AND B-3, Journal of chromatography, 815(1), 1998, pp. 41-47
Citation: K. Duncan et P. Heald, CUTANEOUS T-CELL LYMPHOMA - CENTURIES OF CONTROVERSY, Seminars in cutaneous medicine and surgery, 17(2), 1998, pp. 133-140
Citation: K. Duncan et C. Guthrie, USING GENETICS TO PROBE THE RELATIONSHIP BETWEEN THE PROCESSING AND TRANSPORT MACHINERIES, Molecular biology of the cell, 9, 1998, pp. 39-39
Citation: P. Heald et al., CONVERSION FROM CD4-CELL LYMPHOMA( TO CD8+ EXPRESSION AS A TERMINAL EVENT IN CUTANEOUS T), Journal of investigative dermatology, 110(4), 1998, pp. 642-642
Authors:
DUNCAN K
HEALD P
TALLINI G
CROTTY P
GLUSAC E
Citation: K. Duncan et al., UTILITY OF PCR AMPLIFICATION OF T-CELL RECEPTOR REARRANGEMENTS IN THEDEFINITION OF CUTANEOUS T-CELL LYMPHOMA RELAPSE, Journal of investigative dermatology, 110(4), 1998, pp. 645-645
Authors:
SKARZYNSKI T
KIM DH
LEES WJ
WALSH CT
DUNCAN K
Citation: T. Skarzynski et al., STEREOCHEMICAL COURSE OF ENZYMATIC ENOLPYRUVYL TRANSFER AND CATALYTICCONFORMATION OF THE ACTIVE-SITE REVEALED BY THE CRYSTAL-STRUCTURE OF THE FLUORINATED ANALOG OF THE REACTION TETRAHEDRAL INTERMEDIATE BOUND TO THE ACTIVE-SITE OF THE C115A MUTANT OF MURA, Biochemistry, 37(8), 1998, pp. 2572-2577
Citation: K. Duncan et al., RUNNING EXERCISE MAY REDUCE RISK FOR LUNG AND LIVER-CANCER BY INDUCING ACTIVITY OF ANTIOXIDANT AND PHASE-II ENZYMES, Cancer letters, 116(2), 1997, pp. 151-158
Authors:
DUNCAN K
LEVETIN E
WELLS H
JENNINGS E
HETTENBACH S
BAILEY S
LAWLOR K
SUBLETTE K
FISHER JB
Citation: K. Duncan et al., MANAGED BIOREMEDIATION OF SOIL CONTAMINATED WITH CRUDE-OIL - SOIL CHEMISTRY AND MICROBIAL ECOLOGY 3 YEARS LATER, Applied biochemistry and biotechnology, 63-5, 1997, pp. 879-889
Citation: K. Duncan, TOWARDS THE NEXT-GENERATION OF DRUGS AND VACCINES FOR TUBERCULOSIS (NOV, PG 861, 1997), Chemistry and Industry, (24), 1997, pp. 984-984
Citation: K. Duncan et al., THE COMPLEMENTARY ROLE OF ECHOPLANAR MAGNETIC-RESONANCE-IMAGING AND 3-DIMENSIONAL ULTRASONOGRAPHY IN FETAL LUNG ASSESSMENT, American journal of obstetrics and gynecology, 177(1), 1997, pp. 244-245
Citation: K. Duncan, TUBERCULOSIS - CURRENT STATUS AND RECENT DEVELOPMENTS IN DIAGNOSTICS,DRUGS AND VACCINES, Expert opinion on therapeutic patents, 6(2), 1996, pp. 175-185
Authors:
SKARZYNSKI T
MISTRY A
WONACOTT A
HUTCHINSON SE
KELLY VA
DUNCAN K
Citation: T. Skarzynski et al., STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE, AN ENZYME ESSENTIAL FOR THE SYNTHESIS OF BACTERIAL PEPTIDOGLYCAN, COMPLEXED WITH SUBSTRATE UDP-N-ACETYLGLUCOSAMINE AND THE DRUG FOSFOMYCIN, Structure, 4(12), 1996, pp. 1465-1474
Citation: K. Duncan et al., TREAT PATIENTS WITH KINDNESS DURING MAGNETIC-RESONANCE-IMAGING, BMJ. British medical journal, 312(7043), 1996, pp. 1421-1421
Authors:
CAMBAU E
JARLIER V
GROSSET J
BENSON CA
BOTTGER EC
TELENTI A
GORDON S
HOULDSWORTH S
DUNCAN K
ROBERTS IS
ANDREW PW
BARROW WW
MADDRY JA
RASTOGI N
FALKINHAM JO
Citation: E. Cambau et al., SOLVING THE DILEMMA OF ANTIMYCOBACTERIAL CHEMOTHERAPY - 13TH FORUM INMICROBIOLOGY - DISCUSSION, Research in microbiology, 147(1-2), 1996, pp. 112-121
Authors:
ORAM M
DOSANJH B
GORMLEY NA
SMITH GV
FISHER LM
MAXWELL A
DUNCAN K
Citation: M. Oram et al., MODE OF ACTION OF GR122222X, A NOVEL INHIBITOR OF BACTERIAL-DNA GYRASE, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 473-476